• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Esperion Therapeutics Inc

+ Add to Watchlist

ESPR:US

15.1200 USD 0.6300 4.35%

As of 20:10:00 ET on 07/23/2014.

Snapshot for Esperion Therapeutics Inc (ESPR)

Open: 14.7400 Day's Range: 14.7400 - 15.1300 Volume: 18,592
Previous Close: 14.4900 52wk Range: 10.9000 - 20.1000 1-Yr Rtn: -10.85%

Stock Chart for ESPR

No chart data available.
  • ESPR:US 15.1200
  • 1D
  • 1M
  • 1Y
14.4900
Interactive ESPR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESPR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.3171
Est. EPS (USD) (12/2014) -2.3570
Est. PEG Ratio -
Market Cap (M USD) 233.42
Shares Outstanding (M) 15.44
30 Day Average Volume 22,124
Price/Book (mrq) 3.4689
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESPR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ESPR

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral, small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

Roger S NewtonChairman/Chief Scientific Ofcr/Co-FounderTimothy M Mayleben "Tim"President/CEO
Noah L RosenbergChief Medical Officer
More Company Profile & Key Executives for ESPR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil